Logo
Login
$PCSA
$1.80 -$0.02 (0.83%) Close

Company Executives

$PCSA Management Team

Dr. David Young

President - Research and Development

Director

Age 72
Compensation $305.4K USD
Sex Male

Mr. Patrick Lin

Chief Business and Strategy Officer

Age 59
Compensation $1.043M USD
Sex Male

Ms. Wendy Guy

Founder

Chief Administrative Officer

Age 60
Compensation $1.020M USD
Sex Female

Dr. Sian Bigora

Chief Development Officer and Regulatory Officer

Founder

Age 64
Compensation $328.3K USD
Sex Female

Mr. Russell Skibsted

Chief Financial Officer

Age 66
Compensation -
Sex Male

Mr. Justin Yorke

Independent Chairman of the Board

Age 58
Compensation $93.00K USD
Sex Male

Mr. George Ng

Chief Executive Officer

Director

Age 51
Compensation $521.0K USD
Sex Male

Board of Directors

From the proxy statement filed Jun 18, 2026
Directors
6
serving now
Independent
4 of 4
stated in the proxy; 2 not stated
Average tenure
5.8 years
from year joined
CEO also chairs the board
No
Justin Yorke
Director Age On board Independent Committees Other public boards 2025 pay Source
Justin Yorke
Board chair
 59 2017
9 years
 Independent None stated Splash Beverage Group, Inc $100,000
George Ng
CEO
 52 2023
3 years
 Not stated None stated TuHURA Biosciences, Inc. Paid as CEO
Khoso Baluch
68 2022
4 years
 Independent
Audit Committee Compensation Committee Nominating and Governance Committee
Longeveron, Poxel S.A. $100,000
James Neal
70 2022
4 years
 Independent
Compensation Committee Nominating and Governance Committee
Akari Therapeutics $100,000
Geraldine Pannu
57 2020
6 years
 Independent None stated Royal Business Bank $100,000
David Young
Executive officer
 73 2017
9 years
 Not stated None stated None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

3 disclosed in the proxy filed Jun 18, 2026
CorLyst, LLC
Our President, Research and Development is the Chief Executive Officer of CorLyst, and CorLyst is a shareholder of the Company
Approximately $100,000 and $110,000
2025 and 2024

CorLyst reimburses the Company for shared costs related to payroll, health insurance and rent

With the Company Open in proxy
The Chiliz Group
Issuer of the Chiliz Token; owned 11.0% of our shares of common stock outstanding as of June 1, 2026
$1.2 million in net proceeds
August 4, 2025

Sale of 218,688 shares of the Company's common stock to The Chiliz Group

Open in proxy
The Chiliz Group
Issuer of the Chiliz Token; owned 11.0% of our shares of common stock outstanding as of June 1, 2026
$200,000
February 17, 2026

Sale of an additional 86,956 shares of the Company's common stock to The Chiliz Group

Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans